AXA Investment Managers

AXA Investment Managers operates as a global asset manager with significant activity investing in private equity—including dedicated strategies for global health that back innovative medical device and biopharma firms at late clinical or early commercial stages. It does not conduct clinical trials or have direct clinical results of its own but reports successful exits from portfolio investments such as Alydia Health. Recent notable activity includes establishing Axena Health through acquisition of Renovia assets for women’s pelvic floor disorders treatment. The group emphasizes impact investing with measurable social outcomes alongside financial returns—especially improving access to affordable healthcare solutions worldwide. Pipeline breadth/pipeline/programs are not directly relevant since this entity manages funds rather than develops drugs/devices internally.